Mylan Pharmaceuticals, a pharmaceutical trading and services company, had deductions for advertising and promotional expenses partially disallowed by Indian tax authorities. After the Principal Commissioner overturned the assessment, the tax authority appealed. The Income Tax Appellate Tribunal ruled in favour of the taxpayer in December 2022, finding that the original assessing officer had conducted adequate inquiries and taken a permissible view, meaning the order could not be deemed erroneous ...
Read more